Fig. 3From: Restrictive IgG antibody response against mutated citrullinated vimentin predicts response to rituximab in patients with rheumatoid arthritisBaseline autoantibody profiles of responders and non-responders to RTX. Non-responders (blue) more frequently showed IgA and IgM antibodies against MCV (AMCV) than responders (red), whereas the antibody distribution of rheumatoid factor (RF) and antibodies against cyclic citrullinated peptide was nearly similar in both groupsBack to article page